Home / SME Stocks / Saroja Pharma
Saroja Pharma: IPO, Share Price and Results Since Listing
Saroja Pharma listed on NSE Emerge on 13 September 2023 after an IPO at INR 84 a share. On 11 November 2026 the shares closed at INR 38, 54.76% below the issue price. For H2 FY2026 it reported revenue of INR 31.77 crore (-9.24% on a year earlier) and a profit after tax of INR 1.04 crore.
Key Facts
- IPO dates
- 31 August 2023 to 5 September 2023
- Issue price
- INR 84
- Issue size
- INR 9.11 crore
- Subscription
- 8.44 times
- Lead manager
- Swastika Investmart Limited
- Listing day
- opened at INR 65 (-22.62%), closed at INR 68.25 (-18.75%)
- Listed on NSE Emerge
- 13 September 2023
- Symbol
- SAROJA
- Latest close
- INR 38 on 11 November 2026
- Against issue price
- -54.76%
- Lot size now
- 1,600 shares (INR 60,800 at the latest close)
Results Filed With NSE
Standalone figures, INR crore. Change compares with the same period a year earlier.
| Period | Revenue | Change | Profit after tax | EPS (INR) | Filed | |
|---|---|---|---|---|---|---|
| H2 FY2026 | 31.77 | -9.24% | 1.04 | 2.60 | after listing | 30 May 2026 |
| FY2026 | 70.13 | +30.53% | 1.62 | 4.02 | after listing | 30 May 2026 |
| H1 FY2026 | 38.36 | – | 0.57 | 1.42 | after listing | 13 November 2025 |
| H2 FY2025 | 35 | – | 0.70 | 1.74 | after listing | 8 July 2025 |
| FY2025 | 53.73 | – | 1.03 | 2.57 | after listing | 8 July 2025 |
Promoter Holding
Promoter holding has moved from 73.02% on 12 September 2023 to 73.02% on 30 September 2026 (0 percentage points).
| As of | Promoters | Public |
|---|---|---|
| 30 September 2026 | 73.02% | 26.98% |
| 31 March 2026 | 73.02% | 26.98% |
| 30 September 2025 | 73.02% | 26.98% |
| 31 March 2025 | 73.02% | 26.98% |
| 30 September 2024 | 73.02% | 26.98% |
| 31 March 2024 | 73.02% | 26.98% |
| 30 September 2023 | 73.02% | 26.99% |
| 12 September 2023 | 73.02% | 26.98% |
Next Board Meeting
13 November 2026: Financial results
Sources: NSE Emerge filings (results XBRL, shareholding pattern, board meetings), NSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.